RepliCel Life Sciences Inc. (RP.V)
TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
At close: 01:55PM EST
| Previous Close | 0.1100 |
| Open | 0.1300 |
| Bid | 0.1050 x 0 |
| Ask | 0.1400 x 0 |
| Day's Range | 0.1100 - 0.1400 |
| 52 Week Range | 0.0700 - 0.2500 |
| Volume | |
| Avg. Volume | 8,409 |
| Market Cap | 4.238M |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0590 |
| Earnings Date | Nov 27, 2015 - Nov 30, 2015 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
RepliCel Provides Corporate Update
RepliCel Life Sciences Inc. (TSXV:RP)(OTC PINK:REPCF) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to provide the following corporate update.
- ACCESSWIRE
RepliCel Announces Material Patent Milestones in Key Markets
RepliCel Life Sciences Inc. (OTCPK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing novel, next-generation injection technologies as well as cell-based regenerative medicine products in aesthetics and orthopedics, is pleased to announce the granting of several patents covering novel aspects of the DermaPrecise™ product portfolio, as well as the granting and/or allowance of four other patent applications for its skin rejuvenation
© 2023 Yahoo. All rights reserved.
